BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21548553)

  • 1. s-Allyl cysteine, s-ethyl cysteine, and s-propyl cysteine alleviate β-amyloid, glycative, and oxidative injury in brain of mice treated by D-galactose.
    Tsai SJ; Chiu CP; Yang HT; Yin MC
    J Agric Food Chem; 2011 Jun; 59(11):6319-26. PubMed ID: 21548553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-oxidative, anti-glycative and anti-apoptotic effects of oleanolic acid in brain of mice treated by D-galactose.
    Tsai SJ; Yin MC
    Eur J Pharmacol; 2012 Aug; 689(1-3):81-8. PubMed ID: 22683839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-glycative and anti-inflammatory effects of protocatechuic acid in brain of mice treated by D-galactose.
    Tsai SJ; Yin MC
    Food Chem Toxicol; 2012 Sep; 50(9):3198-205. PubMed ID: 22687555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy isoflavones attenuate oxidative stress and improve parameters related to aging and Alzheimer's disease in C57BL/6J mice treated with D-galactose.
    Hsieh HM; Wu WM; Hu ML
    Food Chem Toxicol; 2009 Mar; 47(3):625-32. PubMed ID: 19146912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-apoptotic and anti-glycative effects of asiatic acid in the brain of D-galactose treated mice.
    Chao PC; Yin MC; Mong MC
    Food Funct; 2015 Feb; 6(2):542-8. PubMed ID: 25504333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor κB-dependent anti-inflammatory effects of s-allyl cysteine and s-propyl cysteine in kidney of diabetic mice.
    Mong MC; Yin MC
    J Agric Food Chem; 2012 Mar; 60(12):3158-65. PubMed ID: 22394022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiamine deficiency increases β-secretase activity and accumulation of β-amyloid peptides.
    Zhang Q; Yang G; Li W; Fan Z; Sun A; Luo J; Ke ZJ
    Neurobiol Aging; 2011 Jan; 32(1):42-53. PubMed ID: 19233513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiglycative effects of protocatechuic acid in the kidneys of diabetic mice.
    Lin CY; Tsai SJ; Huang CS; Yin MC
    J Agric Food Chem; 2011 May; 59(9):5117-24. PubMed ID: 21456600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of s-allyl cysteine and s-propyl cysteine on acetaminophen-induced hepatotoxicity in mice.
    Hsu CC; Lin CC; Liao TS; Yin MC
    Food Chem Toxicol; 2006 Mar; 44(3):393-7. PubMed ID: 16181716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I; Arbel M; Solomon B
    Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of Abeta metabolism-associated molecules from D-galactose/AlCl(3) induced mouse brain.
    Luo Y; Niu F; Sun Z; Cao W; Zhang X; Guan D; Lv Z; Zhang B; Xu Y
    Mech Ageing Dev; 2009 Apr; 130(4):248-52. PubMed ID: 19150622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructo-oligosaccharide systemically diminished D-galactose-induced oxidative molecule damages in BALB/cJ mice.
    Hsia CH; Wang CH; Kuo YW; Ho YJ; Chen HL
    Br J Nutr; 2012 Jun; 107(12):1787-92. PubMed ID: 21929837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
    Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL
    Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain.
    Joshi G; Hardas S; Sultana R; St Clair DK; Vore M; Butterfield DA
    J Neurosci Res; 2007 Feb; 85(3):497-503. PubMed ID: 17171703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
    Qi XL; Nordberg A; Xiu J; Guan ZZ
    Neurochem Int; 2007; 51(6-7):377-83. PubMed ID: 17493709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.